BEDFORD, Mass., June 25 /PRNewswire-FirstCall/ -- Hologic, Inc.
(Nasdaq: HOLX) today announced that the Federal Trade Commission granted early
termination of the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the 'HSR Act'), on June 24, 2008, in
connection with Hologic's previously announced tender offer for all of the
outstanding shares of the common stock of Third Wave Technologies, Inc.
(Nasdaq: TWTI). The early termination of the waiting period under the HSR Act
satisfies the conditions to the tender offer related to the expiration or
termination of any applicable waiting periods under the HSR Act and other
state and foreign regulatory laws relating to the restraint of trade or
lessening of competition. The tender offer remains subject to certain other
conditions described in the Offer to Purchase.
As previously announced, Hologic commenced a Tender Offer on June 18, 2008
for all of the outstanding shares of Third Wave common stock for $11.25 per
share in cash. The tender offer is scheduled to expire at 12:00 midnight, New
York City time, on July 16, 2008.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium
diagnostics, medical imaging systems and surgical products dedicated to
serving the healthcare needs of women. Hologic's core business units are
focused on breast health, diagnostics, GYN surgical, and skeletal health.
Hologic provides a comprehensive suite of technologies with products for
mammography and breast biopsy, radiation treatment for early-stage breast
cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis
assessment, preterm birth risk assessment, and mini C-arm for extremity
imaging. For more information visit www.hologic.com.
Additional Information
This description contained herein is neither an offer to purchase nor a
solicitation of an offer to sell shares of Third Wave. The tender offer is
being made pursuant to a Tender Offer Statement and related materials. Third
Wave shareholders are advised to read the Tender Offer Statement and related
materials filed by Hologic with the U.S. Securities and Exchange Commission
(the 'SEC'). At the time the tender offer commenced, Hologic and Thunder Tech
Corp. (a wholly- owned subsidiary of Hologic) filed a Tender Offer Statement
on Schedule TO containing an Offer to Purchase, the form of the letter of
transmittal and other documents relating to the tender offer, and Third Wave
filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect
to the tender offer. These documents contain important information about the
tender offer, including the terms and conditions of the tender offer, and
shareholders of Third Wave are urged to read them carefully. Shareholders of
Third Wave are able to obtain a free copy of these documents at
http://www.hologic.com and the website maintained by the SEC at
http://www.sec.gov. In addition, shareholders are able to obtain a free copy
of these documents by contacting Hologic or Third Wave.
Contact:
Glenn P. Muir
Executive Vice President & CFO
Hologic, Inc.
(781) 999-7300
Frances Doria
Director, Investor Relations
Hologic, Inc.
(781) 999-7377
SOURCE Hologic, Inc.
